Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950103-23-014295
Filing Date
2023-09-29
Accepted
2023-09-29 16:05:40
Documents
12
Period of Report
2023-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A dp200715_8ka.htm   iXBRL 8-K/A 30165
  Complete submission text file 0000950103-23-014295.txt   208637

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bhc-20230918.xsd EX-101.SCH 3024
3 XBRL LABEL FILE bhc-20230918_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bhc-20230918_pre.xml EX-101.PRE 22366
6 EXTRACTED XBRL INSTANCE DOCUMENT dp200715_8ka_htm.xml XML 4529
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-14956 | Film No.: 231295505
SIC: 2834 Pharmaceutical Preparations